Skip to content

Efficacy of human milk supplementation on performance and adaptations

Efficacy of human milk oligosaccharide 6'-sialyllactose supplementation on exercise performance and training adaptations

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN50097942
Enrollment
24
Registered
2026-01-26
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary supplementation of 6'-SL supplement (900 mg/day for 12 weeks) to enhance the benefits of participation in a resistance-training program. Other

Interventions

All participants will participate in an exercise training program (two upper body and two lower body workouts per week, consisting of a five-minute warm-up, light stretching, and a periodized resistan

Sponsors

GeneChem Inc
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Has given voluntary, written, informed consent to participate in the study 2. Healthy males between the ages of 18 - 40 years 3. Body Mass Index (BMI) less that 40 kg/m2 and/or body fat < 35% 4. Recreationally active individuals capable of performing a whole-body resistance-training and moderate-intensity aerobic exercise program 5. Willing to maintain consistent sleep duration the evening before the study visits

Exclusion criteria

Exclusion criteria: 1. Plan major changes in lifestyle (i.e., diet, dieting, exercise levels, travel) during the study 2. Have a recent history (5%) 3. Have an orthopedic limitation that would prevent participation in a general fitness program 4) Have uncontrolled heart disease, hypertension, diabetes, thyroid disease, cancer, neurological disease, or untreated psychotic or major depressive disorder 5. Have taken muscle-building supplements (e.g., creatine, protein) during the last four weeks or medications that may affect muscle mass or exercise training adaptations 6. Have a known allergy to milk protein 7. Inability to commit to perform and complete the 12-week training program

Countries

United States of America

Contacts

Public ContactChristopher Rasmussen
crasmussen@tamu.edu+1 9794581741

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 15, 2026